Sionna Therapeutics, Inc. (SION)
5.59
+0.30
(+5.67%)
USD |
NASDAQ |
Aug 24, 16:00
5.55
-0.04
(-0.72%)
After-Hours: 20:00
Sionna Therapeutics Debt to Equity Ratio : 0.0304 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0304 |
| March 31, 2026 | 0.0291 |
| December 31, 2025 | 0.0283 |
| September 30, 2025 | 0.0279 |
| June 30, 2025 | 0.0275 |
| March 31, 2025 | 0.027 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.0585 |
| September 30, 2024 | 0.055 |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 0.3067 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Immunic, Inc. | 0.0044 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 283.25M |
| Total Liabilities (Quarterly) | 17.47M |
| Shareholders Equity (Quarterly) | 265.78M |
| Current Ratio | 20.05 |
| Net Debt Paydown Yield | 0.01% |